Abstract
Mesothelioma is an aggressive tumor arising from the mesothelium, and is usually associated with previous exposure to asbestos. The incubation period of the tumor may be described as 30-40 years, and the prognosis is dismal. Recently, serum markers for the diagnosis of mesothelioma have been reported as candidates. In this paper, we mini-reviewed the potential utility of ELISA systems as serum diagnostic markers for asbestos-related mesothelioma.
MeSH terms
-
Asbestos / toxicity*
-
Biomarkers, Tumor / blood
-
Blood Proteins / analysis
-
Carcinogens / toxicity*
-
Enzyme-Linked Immunosorbent Assay*
-
GPI-Linked Proteins
-
Humans
-
Membrane Glycoproteins / blood*
-
Mesothelin
-
Mesothelioma / blood*
-
Mesothelioma / diagnosis
-
Mesothelioma / etiology
-
Oncogene Proteins / blood*
-
Pleural Neoplasms / blood*
-
Pleural Neoplasms / diagnosis
-
Pleural Neoplasms / etiology
Substances
-
Biomarkers, Tumor
-
Blood Proteins
-
Carcinogens
-
Erc protein, human
-
GPI-Linked Proteins
-
Membrane Glycoproteins
-
Oncogene Proteins
-
Asbestos
-
Mesothelin